arrow_back Back to App

Protecting Medical Research Funding: Stability for NIH

This act aims to ensure stable funding for medical research conducted by the National Institutes of Health (NIH). This means that funds allocated for these studies will be more difficult to divert for other purposes, potentially contributing to the continuous development of new drugs and therapies, positively impacting public health.
Key points
Funds allocated to the National Institutes of Health (NIH) will be protected from sudden redirection for other purposes, unless Congress explicitly allows it through a new law.
The Secretary of Health and Human Services will be required to regularly certify compliance with NIH funding rules, increasing transparency and accountability.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_HR_2855
Sponsor: Rep. Kennedy, Timothy M. [D-NY-26]
Process start date: 2025-04-10
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Protecting Medical Research Funding Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_HR_2855.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2025-04-10.

What are the main provisions?

Key points include:

  • Funds allocated to the National Institutes of Health (NIH) will be protected from sudden redirection for other purposes, unless Congress explicitly allows it through a new law.
  • The Secretary of Health and Human Services will be required to regularly certify compliance with NIH funding rules, increasing transparency and accountability.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Kennedy, Timothy M. [D-NY-26].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-22.

CATEGORIES

Health Public Investments